Bio-Rad - Preparing for a Stress-free QC Audit

CLSI introduces Country- Based Pricing to increase global access to laboratory standards

The Clinical and Laboratory Standards Institute (CLSI) has implemented new Country-Based Pricing for countries that meet economic criteria set forth by the World Bank. Effective immediately, this pricing structure will enable laboratories and clinicians around the world, regardless of resources, to more feasibly access CLSI’s robust library of standards documents, training and support materials, and membership.

“As part of our mission to promote the use of safe and effective laboratory practices around the world, CLSI is committed to making our standards, guidelines, and tools accessible to all users,” said Barb Jones, CLSI CEO. “CLSI’s consensus-based standards uniquely incorporate the deep knowledge and expertise of the world’s leaders in laboratory medicine and are widely considered the gold standard for laboratory practice. We are energized by the potential for Country-Based Pricing to support professionals around the world who contribute daily to global health and safety.”

CLSI’s Country-Based Pricing structure correlates to World Bank Income Groups, which are determined by each country’s gross national income, and updated annually in August. Under this model, low- and lower-middle income countries receive a 90% price discount. Upper-middle income countries receive a 50% discount off list prices.

In total, Country-Based Pricing offers new discounted pricing to more than 136 lower- and middle- income countries this year. Discounts are applied upon purchase and / or the establishment of a new CLSI membership, or on renewal dates for current members. These discounts apply to well over 350 critical laboratory resources such as CLSI M100 – Performance Standards for Antimicrobial Susceptibility Testing, Evaluation Protocol guidelines, Point-of-Care Testing and Newborn Screening resources, and Quality Management essentials.

shutterstock 639884194 2